Covance
Also known as: Convance | Covanance Honolulu CRU | Covance | Covance Basel Research Unit AG - Lettenweg 118 - CH - 4123 Allschwil / Switzerland | Covance Bioanalytical Services, LLC | Covance Central Laboratory Services | Covance Central Laboratory Services, LP | Covance Clincial Research Unit, Inc. | Covance Clinical | Covance Clinical Development Services | Covance Clinical Laboratory Unit | Covance Clinical Pharmacology | Covance Clinical Pharmacology Inc. | Covance Clinical Pharmacology, Inc. | Covance Clinical Research | Covance Clinical Research Center Inc. | Covance Clinical Research - Evansville, IN | Covance Clinical research Unit | Covance Clinical Research Unit | Covance Clinical Research Unit AG | Covance Clinical Research Unit AG, Lettenweg 118, CH-4123 Allschwil (Basel), Switzerland | Covance Clinical Research Unit (CRU) Ltd. | Covance Clinical Research Unit - Dallas | Covance Clinical Research Unit, Evansville | Covance Clinical Research Unit, Hyde Street, Leeds, UK | COVANCE CLINICAL RESEARCH UNIT Ltd - Springfield House - Hyde Street - Leeds - LS2 9LH - UK | Covance Clinical Research Unit, Madison, WI, USA | Covance CRU | Covance CRU Inc. | Covance CRU, Inc | Covance CRU, Inc. | Covance CRU Leeds | Covance CRU Ltd | Covance CRU Ltd. | Covance Dallas Clinical Research Unit | Covance GFI Research, Evansville, IN 47714 | Covance Global Clinical Research Unit Inc. | Covance Harrogate | Covance Laboratories, Inc | Covance Ltd | Covance Research - Daytona Beach, Fl | Covance Research, Madison, WI | Covance Research Unit AG | Medical Director, Covance-Evansville, Evansville, IN 47710
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2003Last known activity
Jan 31, 2022
Timeline
1990s
- Jan 1, 1996
Covance— Founded
2000s
- Mar 15, 2009
Swiss Pharma— Acquired
Drugs by trial phase (223 distinct, 223 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (22 own, 0 via acquisition)
Phase 2 (42 own, 1 via acquisition)
Phase 1 (145 own, 2 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Acute Radiation Syndrome
- Amyloidosis
- Amyotrophic Lateral Sclerosis
- Angioedema
- Angioedemas, Hereditary
- Anthrax
- Arthritis
- Arthritis, Gouty
- Arthritis, Rheumatoid
- Aspergillosis
- Asthma
- Atrial Fibrillation
- Bacterial Infections
- beta-Thalassemia
- Body Weight
- Bone Marrow Diseases
- Bone Neoplasms
- Candidiasis
- Candidiasis, Vulvovaginal
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Cardiotoxicity
- Cardiovascular Diseases
- Carpal Tunnel Syndrome
- Cicatrix
- Cicatrix, Hypertrophic
- Colitis
- Colitis, Ulcerative
- Colonic Polyps
- Colorectal Neoplasms
- Constipation
- Coronary Artery Disease
- Coronavirus Infections
- Cystic Fibrosis
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Dyslipidemias
- Eczema
- Epilepsy
- Erectile Dysfunction
- Essential Hypertension
- Familial Primary Pulmonary Hypertension
- Fatty Liver
- Fibrosis
- Gastroparesis
- Glioblastoma
- Gout
- Head and Neck Neoplasms
- Heart Diseases
- Heart Failure
- Hepatitis
- Hepatitis C
- Hepatitis C, Chronic
- Hidradenitis
- Hidradenitis Suppurativa
- HIV Infections
- Huntington Disease
- Hypercholesterolemia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperphosphatemia
- Hypertension
- Hypertension, Pulmonary
- Hyperuricemia
- Idiopathic Pulmonary Fibrosis
- Inflammation
- Influenza, Human
- Ischemia
- Kidney Diseases
- Liver Cirrhosis
- Liver Diseases
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Malaria
- Melanoma
- Motor Neuron Disease
- Mucopolysaccharidoses
- Mucopolysaccharidosis II
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Myocardial Ischemia
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Non-alcoholic Fatty Liver Disease
- Osteoarthritis, Knee
- Osteoporosis
- Osteoporosis, Postmenopausal
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Parkinson Disease
- Pericarditis
- Polycystic Ovary Syndrome
- Polycythemia
Subsidiaries (3 direct, 3 total across the full acquisition tree)
Recent trials (50)
- NCT04552691CollaboratorN/A—
- NCT05121948CollaboratorPhase 1Jan 31, 2022
- NCT05084560CollaboratorPhase 1Nov 1, 2021
- NCT04703842CollaboratorPhase 1/Phase 2Oct 31, 2021
- NCT05082779CollaboratorPhase 1Oct 26, 2021
- NCT04880109CollaboratorPhase 2Oct 20, 2021
- NCT05159895Overall official - principal investigatorPhase 1Sep 24, 2021
- NCT04938635CollaboratorPhase 2Sep 20, 2021
- NCT05006118CollaboratorPhase 1Sep 1, 2021
- NCT05006118Overall official - principal investigatorPhase 1Sep 1, 2021
- NCT04801095CollaboratorPhase 1Jul 14, 2021
- NCT04662528CollaboratorPhase 3Jun 30, 2021
- NCT04817670CollaboratorPhase 2Jun 9, 2021
- NCT04834778CollaboratorPhase 1Jun 8, 2021
- NCT04796194CollaboratorPhase 2Jun 1, 2021
Details
- Founded
- Princeton, NJ, US Jan 1, 1996
- Last known activity
- Jan 31, 2022